NCT06062771View on ClinicalTrials.gov

Efficacy and Safety of the Use of Ophthalmic Viscosurgical Devices (OVD) FIDIAL PLUS vs IAL®-F During Cataract Surgery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 23, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

January 1, 2023

Conditions
Cataract
Interventions
DEVICE

FIDIAL PLUS

1.8% solution of sodium hyaluronate that is derived from a bacterial fermentation (not of animal origin).

DEVICE

IAL®-F

Animal derived 1.8% sodium hyaluronate equivalent to FIDIAL PLUS

Trial Locations (1)

37126

Azienda Ospedaliera Universitaria Integrata di Verona, Verona

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY